Filter posts

Former Senator Kyl: Abuse of the Patent Review Hurts American Innovation

Earlier this week The Hill ran an op-ed by Former Arizona Senator Jon Kyl in …

Biotech Industry Establishes a Much-Needed Presence in Geneva

Multilateral Organizations, based in Geneva, Switzerland, including the World Health Organization (WHO), World Intellectual Property …

DEA Drug Take Back Day Breaks Collection Record

Last week, the Drug Enforcement Administration’s 14th Prescription Drug Take Back Day collected a record-setting …

Jim Greenwood Talks Biotech Innovation With Bloomberg Radio

While in Boston this week, BIO CEO Jim Greenwood sat down with Bloomberg Boston Bureau …

ONE HEALTH event discusses solutions and innovations in biotechnology in Brazil

Joseph Damond, Executive Vice President of International Affairs at BIO led a keynote discussion on …

BIO to Senate Judiciary: Stop Abuses at PTO

Gamesmanship of the United States Patent and Trademark Office’s (PTO) Inter Partes Review (IPR) process …

Double Jeopardy at the PTO Threatens Healthcare Innovation

There has been no shortage of commentary related to the efforts of Allergan to shield …

Strong Public Policy is the Bedrock of Biotech Economic Growth

As noted in the recently-released 2017 BIO publication Bioscience Innovation in the States: Job Creation …

California Senate Passed Drug Price Reporting & Transparency Bill

This week the California Senate passed a tremendously flawed bill that would hamper the ability …

ICYMI: Drug Pricing Bill Is Bad for Business, Patients

Researchers and biotech leaders continue to discover new cures and treatments that are making a …